1. Home
  2. VKTX vs AIR Comparison

VKTX vs AIR Comparison

Compare VKTX & AIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • AIR
  • Stock Information
  • Founded
  • VKTX 2012
  • AIR 1951
  • Country
  • VKTX United States
  • AIR United States
  • Employees
  • VKTX N/A
  • AIR N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • AIR Aerospace
  • Sector
  • VKTX Health Care
  • AIR Industrials
  • Exchange
  • VKTX Nasdaq
  • AIR Nasdaq
  • Market Cap
  • VKTX 3.5B
  • AIR 2.8B
  • IPO Year
  • VKTX 2015
  • AIR 1988
  • Fundamental
  • Price
  • VKTX $40.03
  • AIR $75.40
  • Analyst Decision
  • VKTX Strong Buy
  • AIR Strong Buy
  • Analyst Count
  • VKTX 13
  • AIR 5
  • Target Price
  • VKTX $86.92
  • AIR $83.60
  • AVG Volume (30 Days)
  • VKTX 4.6M
  • AIR 435.9K
  • Earning Date
  • VKTX 07-23-2025
  • AIR 09-22-2025
  • Dividend Yield
  • VKTX N/A
  • AIR N/A
  • EPS Growth
  • VKTX N/A
  • AIR N/A
  • EPS
  • VKTX N/A
  • AIR 0.35
  • Revenue
  • VKTX N/A
  • AIR $2,780,500,000.00
  • Revenue This Year
  • VKTX N/A
  • AIR $5.16
  • Revenue Next Year
  • VKTX $338.60
  • AIR $6.43
  • P/E Ratio
  • VKTX N/A
  • AIR $215.37
  • Revenue Growth
  • VKTX N/A
  • AIR 19.91
  • 52 Week Low
  • VKTX $18.92
  • AIR $46.51
  • 52 Week High
  • VKTX $81.73
  • AIR $86.43
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 69.97
  • AIR 51.67
  • Support Level
  • VKTX $39.35
  • AIR $71.43
  • Resistance Level
  • VKTX $41.68
  • AIR $78.75
  • Average True Range (ATR)
  • VKTX 2.06
  • AIR 2.15
  • MACD
  • VKTX 0.56
  • AIR -0.08
  • Stochastic Oscillator
  • VKTX 84.10
  • AIR 54.23

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About AIR AAR Corp.

AAR Corp is engaged in providing products and services to aviation, government and defense market. It operates in segments namely: The parts supply segment majorly consists of sales and leasing of USM and aftermarket distribution of new, OEM-supplied replacement parts; Repair & Engineering segment provides airframe maintenance, component repair, and landing gear overhaul services; Integrated Solutions segment consists of its fleet management and operations of customer-owned aircraft, customized performance-based supply chain logistics programs in support of the U.S. Department of Defense, flight hour component inventory; and The Expeditionary Services segment consists of products and services supporting the movement of equipment and personnel by the U.S. and foreign governments and NGOs.

Share on Social Networks: